Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
Aug 2009 - Eur. J. Cancer; 45(11):1879-0852 [PMID:19361982]
[Franckena M] [Fatehi D] [de Bruijne M] [Canters RA] [van Norden Y] [Mens JW] [van Rhoon GC] [van der Zee J]

Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
Jan 2009 - Int. J. Radiat. Oncol. Biol. Phys.; 73(1):1879-355X [PMID:18990505]
[Franckena M] [Lutgens LC] [Koper PC] [Kleynen CE] [van der Steen-Banasik EM] [Jobsen JJ] [Leer JW] [Creutzberg CL] [Dielwart MF] [van Norden Y] [Canters RA] [van Rhoon GC] [van der Zee J]

Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
Apr 2008 - Int. J. Radiat. Oncol. Biol. Phys.; 70(4):0360-3016 [PMID:17881144]
[Franckena M] [Stalpers LJ] [Koper PC] [Wiggenraad RG] [Hoogenraad WJ] [van Dijk JD] [Wárlám-Rodenhuis CC] [Jobsen JJ] [van Rhoon GC] [van der Zee J]

RF-power and temperature data analysis of 444 patients with primary cervical cancer: deep hyperthermia using the Sigma-60 applicator is reproducible.
Jan 2008 - Int J Hyperthermia; 23(8):0265-6736 [PMID:18097850]
[Fatehi D] [van der Zee J] [de Bruijne M] [Franckena M] [van Rhoon GC]

Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area.
Sep 2007 - Int J Hyperthermia; 23(5):0265-6736 [PMID:17701535]
[Franckena M] [De Wit R] [Ansink AC] [Notenboom A] [Canters RA] [Fatehi D] [Van Rhoon GC] [Van Der Zee J]